(PR-inside.com) http://www.koronispharma.com - Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company's Scientific Advisory Board and Jeff Parkins has been promoted to Vice President, Clinical Development. Dr. Fletcher was appointed Dean of the University of Nebraska Medical Center School of Pharmacy in 2007. Prior to that time he served as professor and director of the Antiviral Pharmacology laboratory at University of Colorado. For more than two decades, Dr. Fletcher has focused his research and practice toward the pharmacology of antiviral agents. He is considered one ..
More...
More...